# Analysis of Reporting of Cutaneous Toxicities Associated With Immune Checkpoint Inhibitors

> **NCT04898751** · — · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 2214 (actual)

## Conditions studied

- Cutaneous Toxicity From ICI Therapy

## Interventions

- **DRUG:** Immune checkpoint inhibitor (ICI)

## Key facts

- **NCT ID:** NCT04898751
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01-01
- **Primary completion:** 2020-08-31
- **Final completion:** 2020-08-31
- **Target enrollment:** 2214 (ACTUAL)
- **Last updated:** 2021-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04898751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04898751, "Analysis of Reporting of Cutaneous Toxicities Associated With Immune Checkpoint Inhibitors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04898751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*